Prof. Dr. med. Stephan Achenbach



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe (2021) Hageman S, Pennells L, Ojeda F, Kaptoge S, Kuulasmaa K, De Vries T, Xu Z, et al. Journal article Impact of conscious sedation and general anesthesia on periprocedural outcomes in Watchman left atrial appendage closure (2021) Kleinecke C, Allakkis W, Buffle E, Liu XX, Mohrez Y, Gloekler S, Brachmann J, et al. Journal article 'Well-being paradox' revisited: a cross-sectional study of quality of life in over 4000 adults with congenital heart disease (2021) Andonian CS, Freilinger S, Achenbach S, Ewert P, Gundlach U, Hoerer J, Kaemmerer H, et al. Journal article Predictors of scaffold failure and impact of optimized scaffold implantation technique on outcome: Results from the German-Austrian ABSORB RegIstRy (2021) Boeder NF, Kastner J, Mehilli J, Muenzel T, Naber C, Neumann T, Richardt G, et al. Journal article Everolimus eluting bioresorbable vascular scaffolds in patients with acute coronary syndromes: Two-year results from the German-Austrian ABSORB registry (2021) Tröbs M, Achenbach S, Nef HM, Gori T, Naber C, Neumann T, Richardt G, et al. Journal article Acute Mechanical Performance of Magmaris vs. DESolve Bioresorbable Scaffolds in a Real-World Scenario (2021) Boeder NF, Doerr O, Koepp T, Blachutzik F, Achenbach S, Elsaesser A, Hamm CW, Nef HM Journal article Investigation of wall shear stress in cardiovascular research and in clinical practice—from bench to bedside (2021) Urschel K, Tauchi M, Achenbach S, Dietel B Journal article, Review article The tobacco endgame—eradicating a worsening epidemic (2021) Willett J, Achenbach S, Pinto FJ, Poppas A, Elkind MS Journal article, Editorial THE SGLT2 INHIBITOR EMPAGLIFLOZIN REDUCES TISSUE SODIUM CONTENT IN PATIENTS WITH CHRONIC HEART FAILURE (2021) Kolwelter J, Kannenkeril D, Linz P, Jung S, Nagel AM, Bosch A, Ott C, et al. Conference contribution EFFECTS OF THE SGLT2 INHIBITOR EMPAGLIFLOZIN ON VASCULAR FUNCTION IN PATIENTS WITH CHRONIC HEART FAILURE (2021) Kolwelter J, Bosch A, Jung S, Linz P, Kannenkeril D, Nagel AM, Ott C, et al. Conference contribution